Effect of icotinib on advanced lung adenocarcinoma patients with sensitive EGFR mutation detected in ctDNA by ddPCR

BACKGROUND: Whether or not EGFR mutation status detected by ddPCR in plasma predicts the effect of icotinib on patients with advanced lung adenocarcinoma was determined. METHODS: Plasma and matched tissue specimens from patients with advanced lung adenocarcinoma were collected prior to icotinib trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Hua-Fei, Lei, Lei, Wu, Li-Xin, Li, Xiao-Feng, Zhang, Qu-Xia, Pan, Wei-Wei, Min, Yong-Hua, Zhu, You-Cai, Du, Kai-Qi, Wang, Min, Wang, Wen-Xian, Xu, Chun-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798205/
https://www.ncbi.nlm.nih.gov/pubmed/35117043
http://dx.doi.org/10.21037/tcr.2019.10.48

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798205/
https://www.ncbi.nlm.nih.gov/pubmed/35117043
http://dx.doi.org/10.21037/tcr.2019.10.48

Ejemplares similares